<DOC>
	<DOCNO>NCT03028675</DOCNO>
	<brief_summary>Twenty subject ( 10 patient 10 age-matched control volunteer ) recruit study . MRI scan take place 3T MRI Scanner ( Skyra Prisma , Siemens Medical Solutions ) locate The NYU Center Biomedical Imaging . MRI scan consist 1-hour brain scan patient control . In first 6 month study , investigator develop test uMT-based APT imaging brain tissue pH measurement use hypercapnia paradigm validate tissue pH change breathe room air 5 % CO2 ( increase tissue acidity ) inhalation . With implementation hypercapnia MRI , pH-weighted imaging validate robustness reproducibility .</brief_summary>
	<brief_title>pH Imaging Multiple Sclerosis</brief_title>
	<detailed_description>The contrast agent ( Gd-DTPA , Gadavist ) inject intravenously ( IV ) arm ( patient ) . The IV insert qualified medical professional CBI . This contrast agent standard dose accordance FDA approve label dose . Controls NOT administer contrast agent .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Healthy male female nonMS control volunteer Medically unstable cardiac , pulmonary , hematological , renal , hepatic dysfunction . Current past DSMIV diagnosis major depression , bipolar psychotic disorder . Contraindications MRI , include Intracranial clip Metal implant External metallic devices/objects/clips within 10mm head Suspected confirm metal eye ( history weld similar activity ) Claustrophobia Cardiac pacemaker pace wire Pregnancy Pregnancy test offer woman childbearing age cost subject History moderate severe head injury , stroke , seizure . Alcoholism drug dependency . Renal liver disease may cause concern related GdDTPA contrast agent . Allergy contrast agent Gadolinium Relapses steroid therapy patient month precede study Patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>